Growth enhancement of transgenic mice expressing human insulin-like growth factor I

395Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

A line of transgenic mice carrying a chimeric gene composed of human insulin-like growth factor I (IGF-I) coding sequences fused to the mouse metallothionein I promoter was generated to study the effects of chronically elevated exposure to IGF-I. Mice in this line overexpress IGF-I in most tissues studied and have circulating IGF-I levels 1.5 times the normal value. This results in a growth response manifested by a 1.3-fold increase in weight as a result of selective organomegaly without an apparent increase in skeletal growth. In addition, expression of the endogenous GH and IGF-I genes is inhibited. These results are consistent with IGF-I playing an important role in the control of somatic growth. © 1988 by The Endocrine Society.

Cite

CITATION STYLE

APA

Mathews, L. S., Hammer, R. E., Behringer, R. R., D’Ercole, A. J., Bell, G. I., Brinster, R. L., & Palmiter, R. D. (1988). Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology, 123(6), 2827–2833. https://doi.org/10.1210/endo-123-6-2827

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free